| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1034498 |
alpha-Amylcinnamaldehyde Dimethyl Acetal (500 mg) |
91-87-2 |
|
| 2911005000 |
|
|
|
| USP-1034501 |
alpha-Amylcinnamyl Acetate (500 mg) |
7493-78-9 |
|
| 2918195000 |
|
|
|
| USP-1034512 |
alpha-Amylcinnamyl Alcohol (500 mg) |
101-85-9 |
|
| 2918195000 |
|
|
|
| USP-1034523 |
alpha-Amylcinnamyl Formate (500 mg) |
7493-79-0 |
|
| 2918992090 |
|
|
|
| USP-1035005 |
Anethole (4 x 0.5 mL) |
4180-23-8 |
UN3077 |
| USP-1036110 |
Aniline (250 mg) |
62-53-3 |
UN1547 |
| USP-1036937 |
p-Anisaldehyde (3 x 500 mg) |
123-11-5 |
UN3082 |
| USP-1036948 |
o-Anisaldehyde (3 x 0.5 mL) |
135-02-4 |
|
| 2912290090 |
|
|
|
| USP-1036959 |
Anise Oil (2 x 0.5 mL) |
8007-70-3 |
|
| 3301296000 |
|
|
|
| USP-1036960 |
Star Anise Oil (500 mg) |
68952-43-2 |
|
| 3301296000 |
|
|
|
| USP-1037011 |
Anisole (1.2 mL/ampule; 3 ampules) |
100-66-3 |
UN2222 |
| USP-1037022 |
Anisyl Butyrate (5 x 0.5 mL) |
6963-56-0 |
|
| 2915600000 |
|
|
|
| USP-1037033 |
Anisyl Propionate (5 x 0.5 mL) |
7549-33-9 |
|
| 2915503000 |
|
|
|
| USP-1037044 |
Anisyl Phenylacetate (5 x 0.5 mL) |
102-17-0 |
|
| 2916397700 |
|
|
|
| USP-1039152 |
Allyl Anthranilate (0.5 mL/ampule; 5 ampules) |
7493-63-2 |
|
| 2922498050 |
|
|
|
| USP-1040504 |
Antithrombin III Human (4.38 IU) |
9000-94-6 |
|
| 3002120090 |
|
|
|
| USP-1040854 |
Apocarotenal (3 x 50 mg) (8′-apo-beta-caroten-8′-al) |
1107-26-2 |
|
| 3204196100 |
|
|
|
| USP-1044200 |
Astaxanthin (Synthetic) (3 x 30 mg) (3,3′-dihydroxy-Beta,Beta-Carotene-4,4′-dione) |
7542-45-2 |
|
| 3204196100 |
|
|
|
| USP-1044210 |
Astaxanthin Esters from Haematococcus pluvialis (5 x 100 mg) |
7542-45-2 (Free Astaxanthin) |
|
| 2106906798 |
|
|
|
| USP-1050949 |
Benzaldehyde Propylene Glycol Acetal (5 x 0.5 mL) |
2568-25-4 |
|
| 2932996560 |
|
|
|
| USP-1050993 |
Benzalkonium Chloride (5 mL of approx. 4% aqueous solution) |
8001-54-5 |
|
| 3402419000 |
|
|
|
| USP-1056005 |
Benzonatate (1 g) |
104-31-4 |
|
| 2922492050 |
|
|
|
| USP-1061901 |
Benzyl Alcohol (500 mg/ampule) |
100-51-6 |
|
| 2906210000 |
|
|
|
| USP-1062008 |
Benzyl Benzoate (5 g) |
120-51-4 |
UN3082 |
| USP-1062019 |
Benzyl Chloride (3 x 200 mg) ((Chloromethyl)benzene) |
100-44-7 |
|
| 2903990002 |
|
|
|
| USP-1062074 |
Benzyl Mercaptan (5 x 0.5 mL) |
100-53-8 |
UN2810 |
| USP-1062085 |
Benzyl Methyl Sulfide (5 x 0.5 mL) |
766-92-7 |
|
| 2930909265 |
|
|
|
| USP-1064058 |
3-Benzyl-4-Heptanone (5 x 0.5 mL) |
7492-37-7 |
|
| 2914399000 |
|
|
|
| USP-1064122 |
N-Benzyl-N-methyl-ethanolamine (3 x 0.2 mL) (2-[benzyl(methyl)amino]ethanol) |
101-98-4 |
|
| 2922199695 |
|
|
|
| USP-1073718 |
Beta-Bisabolol (2 x 100 mg) |
15352-77-9 |
|
| 2906195000 |
|
|
|
| USP-1075203 |
Bis(2-ethylhexyl)maleate (2 g) (Maleic acid, bis(2-ethylhexyl)ester) |
142-16-5 |
|
| 2917192300 |
|
|
|
| USP-1075804 |
Bisoprolol Related Compound E (25 mg) (3,3′-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol)) |
N/A |
|
| 2929909000 |
|
|
|
| USP-1076057 |
Borage Seed Oil (1 g) |
84012-16-8 |
|
| 3301296000 |
|
|
|
| USP-1078573 |
Buspirone Related Compound A (2 x 75 mg) (2-(Piperazin-1-yl)pyrimidine) |
20980-22-7 |
|
| 2933599550 |
|
|
|
| USP-1078824 |
Buspirone Related Compound L (75 mg x 2) (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione) |
21098-11-3 |
|
| 2925190100 |
|
|
|
| USP-1078857 |
Bupropion Related Compound G (50 mg) (2-Bromo-1-(3-chlorophenyl)propan-1-one) |
34911-51-8 |
|
| 2914790000 |
|
|
|
| USP-1081807 |
1-Butanol (1.2 mL/ampule; 3 ampules) |
71-36-3 |
UN1120 |
| USP-1081829 |
2-Butanol (1.2 mL/ampule; 3 ampules) |
78-92-2 |
UN1120 |
| USP-1081842 |
2,3-Butanedithiol (3 x 1 g) |
4532-64-3 |
UN3336 |
| USP-1082606 |
Butyl Acetate (1.2 mL/ampule; 3 ampules) |
123-86-4 |
UN1123 |
| USP-1082617 |
Butyl Cinnamate (500 mg) |
538-65-8 |
|
| 2916399000 |
|
|
|
| USP-1082628 |
Butyl Heptanoate (5 x 0.5 mL) |
5454-28-4 |
|
| 2915900000 |
|
|
|
| USP-1082640 |
Butyl Isothiocyanate (1 mL) |
592-82-5 |
UN2927 |
| USP-1082672 |
Butyl Valerate (1 ml) |
591-68-4 |
|
| 2915600000 |
|
|
|
| USP-1082956 |
Butane-1,3-diol (1 mL) |
107-88-0 |
|
| 2905390000 |
|
|
|
| USP-1082967 |
Butyl Hexanoate (3 x 500 mg) |
626-82-4 |
|
| 2915900000 |
|
|
|
| USP-1083303 |
tert-Butylmethyl ether (1.2 mL/ampule; 3 ampules) |
1634-04-4 |
UN2398 |
| USP-1083529 |
Butyl Palmitate (500 mg) |
111-06-8 |
|
| 2915700100 |
|
|
|
| USP-1084215 |
Allyl Butyrate (5 x 0.5 mL) |
2051-78-7 |
UN1992 |
| USP-1A00260 |
Azacitidine Formyl Amidine Analog (25 mg) (国际冷链运输要求) (N-(Formyl amidino)-N’-Beta-D-ribofuranosylurea) |
65126-88-7 |
|
| 2932190002 |
|
|
|
| USP-1376505 |
Mechlorethamine Hydrochloride (100 mg) (International Restricted Sales Item) |
55-86-7 |
UN2928 |
| USP-1614002 |
Sodium Fluoride (1 g) (International Restricted Sales Item) |
7681-49-4 |
UN1690 |
| USP-1696958 |
Trolamine (3 mL) (International Restricted Sales Item) |
102-71-6 |
|
| 2922150000 |
|
|
|
| USP-1699311 |
Trospium Chloride Related Compound A (20 mg) (Benzilic Acid) (International Restricted Sales Item) |
76-93-7 |
|
| 2918195000 |
|
|
|
| USP-1235999 |
Ephedrine Hydrochloride (200 mg) (List Chemical) |
50-98-6 |
|
| 2939410000 |
|
|
|
| USP-1236007 |
Ephedrine Sulfate (200 mg) (List Chemical) |
134-72-5 |
|
| 2939410000 |
|
|
|
| USP-1240004 |
Ergonovine Maleate (150 mg) (List Chemical) |
129-51-1 |
UN1544 |
| USP-1241506 |
Ergotamine Tartrate (150 mg) (List Chemical) |
379-79-3 |
|
| 2939620000 |
|
|
|
| USP-1534005 |
Phenylpropanolamine Hydrochloride (250 mg) (List Chemical) |
154-41-6 |
|
| 2939440000 |
|
|
|
| USP-1581005 |
Pseudoephedrine Hydrochloride (125 mg) (List Chemical) |
345-78-8 |
|
| 2939420000 |
|
|
|
| USP-1581504 |
Pseudoephedrine Sulfate (200 mg) (List Chemical) |
7460-12-0 |
|
| 2939420000 |
|
|
|
| USP-1699049 |
Tropicamide Related Compound D (15 mg) (List Chemical) (2-phenylacetic acid) |
103-82-2 |
|
| 2916341000 |
|
|
|
| USP-1000408 |
Abacavir Sulfate (200 mg) |
188062-50-2 |
|
| 2933595960 |
|
|
|
| USP-1000419 |
Abacavir Sulfate Racemic (20 mg) (4-[2-amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1)) |
N/A |
|
| 2933599550 |
|
|
|
| USP-1000420 |
Abacavir Related Compound A (20 mg) ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol) |
906626-51-5 |
|
| 2933599550 |
|
|
|
| USP-1000437 |
Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chloropyrimidin-4-yloxy)methyl]cyclopent-2-enyl}-9H-purine-2,6-diamine) |
1443421-69-9 |
|
| 2933599550 |
|
|
|
| USP-1000441 |
Abacavir Related Compound B (20 mg) ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) |
N/A |
|
| 2933599550 |
|
|
|
| USP-1000452 |
Abacavir Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride) |
172015-79-1 |
|
| 2933599550 |
|
|
|
| USP-1000485 |
Abacavir Related Compounds Mixture (15 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1000496 |
Abacavir Stereoisomers Mixture (15 mg) |
N/A |
|
| 2933595960 |
|
|
|
| USP-1000500 |
Abacavir System Suitability Mixture (15 mg) (A mixture containing abacavir sulfate and trans-abacavir) |
N/A |
|
| 2933595960 |
|
|
|
| USP-1000521 |
Acarbose (200 mg) (需冷链运输) |
56180-94-0 |
|
| 2932999000 |
|
|
|
| USP-1000532 |
Acarbose System Suitability Mixture (2 mg) (需冷链运输) (A mixture containing acarbose and impurities A, B, C, D, E, F and G) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1000554 |
Acamprosate Calcium (200 mg) |
77337-73-6 |
|
| 2924190002 |
|
|
|
| USP-1000565 |
Acamprosate Related Compound A (15 mg) (3-aminopropane-1-sulfonic acid) |
3687-18-1 |
|
| 2921196190 |
|
|
|
| USP-1000576 |
Acamprosate Related Compound B (20 mg) |
N/A |
|
| 2924190002 |
|
|
|
| USP-1000601 |
Acebutolol Hydrochloride (125 mg) |
34381-68-5 |
|
| 2924296000 |
|
|
|
| USP-1000612 |
Acebutolol Related Compound A (20 mg) (N-(3-Acetyl-4-hydroxyphenyl)butyramide) |
40188-45-2 |
|
| 2924296000 |
|
|
|
| USP-1000623 |
Acebutolol Related Compound B (20 mg) (N-{3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide) |
22568-64-5 |
|
| 2933599550 |
|
|
|
| USP-1000699 |
Acebutolol Related Compound I (20 mg) (N-{3-Acetyl-4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}butyramide) |
441019-91-6 |
|
| 2924296000 |
|
|
|
| USP-1000818 |
Abiraterone Acetate (200 mg) |
154229-18-2 |
|
| 2937290000 |
|
|
|
| USP-1000829 |
Abiraterone System Suitability Mixture (20 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1001502 |
Acepromazine Maleate (250 mg) |
3598-37-6 |
|
| 2934302300 |
|
|
|
| USP-1002505 |
Acesulfame Potassium (200 mg) |
55589-62-3 |
|
| 2934990005 |
|
|
|
| USP-1003009 |
Acetaminophen (400 mg) |
103-90-2 |
|
| 2924296000 |
|
|
|
| USP-1003010 |
Acetaminophen Related Compound A (15 mg) (4-(acetylamino)phenyl acetate) |
2623-33-8 |
|
| 2924296000 |
|
|
|
| USP-1003027 |
Acetaminophen Related Compound B (30 mg) (N-(4-hydroxyphenyl)propanamide) |
1693-37-4 |
|
| 2924296000 |
|
|
|
| USP-1003031 |
Acetaminophen Related Compound C (50 mg) (N-(2-hydroxyphenyl)acetamide) |
614-80-2 |
|
| 2924296000 |
|
|
|
| USP-1003042 |
Acetaminophen Related Compound D (50 mg) (N-phenylacetamide) |
103-84-4 |
|
| 2924296000 |
|
|
|
| USP-1003064 |
Acetaminophen Related Compound F (50 mg) (p-nitrophenol) |
100-02-7 |
UN1663 |
| USP-1003100 |
Acetaminophen Related Compound J (50 mg) (N-(4-chlorophenyl)acetamide) |
539-03-7 |
|
| 2924296000 |
|
|
|
| USP-1004001 |
Acetanilide Melting Point Standard (1g) (Approximately 114 degrees) |
103-84-4 |
|
| 2924296000 |
|
|
|
| USP-1005004 |
Acetazolamide (2 g) |
59-66-5 |
|
| 2935904000 |
|
|
|
| USP-1005048 |
Acetazolamide Related Compound D (25 mg) (5-Amino-1,3,4-thiadiazole-2-sulfonamide) |
14949-00-9 |
|
| 2935909550 |
|
|
|
| USP-1005059 |
Acetazolamide Related Compound E (25 mg) (5-Acetamido-1,3,4-thiadiazole-2-sulfonic acid potassium salt) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1006506 |
Acetohydroxamic Acid (200 mg) |
546-88-3 |
|
| 2928003000 |
|
|
|
| USP-1491296 |
Oxytocin Identification (15 mg) (需冷链运输) |
6233-83-6 |
UN2811 |
| USP-1491332 |
Paclitaxel (200 mg) |
33069-62-4 |
|
| 2932996560 |
|
|
|
| USP-1491343 |
Paclitaxel Related Compound A (20 mg) (Cephalomannine) |
71610-00-9 |
|
| 2932996560 |
|
|
|
| USP-1491354 |
Paclitaxel Related Compound B (20 mg) (10-deacetyl-7-epipaclitaxel) |
78454-17-8 |
|
| 2932996560 |
|
|
|
| USP-1491365 |
Paclitaxel Impurity Mixture (10 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1491605 |
Paeonia Lactiflora Peeled Root Dry Extract (500 mg) |
NA |
|
| 1302190200 |
|
|
|
| USP-1491616 |
Paeoniflorin (15 mg) |
23180-57-6 |
|
| 2938900000 |
|
|
|
| USP-1491795 |
Paliperidone Resolution Mixture (20 mg) |
N/A |
UN2811 |
| USP-1491809 |
Paliperidone (200 mg) |
144598-75-4 |
UN2811 |
| USP-1491818 |
Paliperidone Related Compound A (20 mg) (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one) |
849903-79-3 |
|
| 2933599550 |
|
|
|
| USP-1491820 |
Paliperidone Related Compound B (20 mg) (6-fluoro-3-(piperidin-4-yl)benzoisoxazole hydrochloride) |
84163-13-3 |
|
| 2934990005 |
|
|
|
| USP-1491831 |
Paliperidone Related Compound C (20 mg) (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one) |
130049-82-0 |
|
| 2934990005 |
|
|
|
| USP-1491842 |
Paliperidone Related Compound D (20 mg) (3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one N-oxide) |
761460-08-6 |
|
| 2934990005 |
|
|
|
| USP-1491900 |
Palmatine Chloride (15 mg) |
10605-02-4 |
|
| 2939790000 |
|
|
|
| USP-1492007 |
Palmitic Acid (500 mg) |
1957/10/3 |
|
| 2915700100 |
|
|
|
| USP-1492200 |
Palonosetron Hydrochloride (100 mg) |
135729-62-3 |
|
| 2933790002 |
|
|
|
| USP-1492211 |
Palonosetron Enantiomer (15 mg) ((3aR)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) |
135729-75-8 |
|
| 2933790002 |
|
|
|
| USP-1492222 |
Palonosetron Related Compound A (15 mg) ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide) |
813425-83-1 |
|
| 2933790002 |
|
|
|
| USP-1492233 |
Palonosetron Related Compound B (15 mg) ((3S)-3-(1-Oxo-5,6-dihydro-1H-benzo[de]isoquinolin-2(4H)-yl)quinuclidine 1-oxide) |
1021456-82-5 |
|
| 2933790002 |
|
|
|
| USP-1492244 |
Palonosetron Related Compound C (15 mg) ((3aS)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) |
135729-76-9 |
|
| 2933790002 |
|
|
|
| USP-1492255 |
Palonosetron Related Compound D (15 mg) ((3aR)-2-[(3S)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) |
135755-51-0 |
|
| 2933790002 |
|
|
|
| USP-1492266 |
Palonosetron Related Compound E (15 mg) (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) |
135729-55-4 |
|
| 2933790002 |
|
|
|
| USP-1492700 |
Pamabrom Related Compound A (30 mg) (8-Chlorotheophylline) |
85-18-7 |
|
| 2939590000 |
|
|
|
| USP-1492801 |
Pamidronate Disodium (100 mg) |
109552-15-0 |
|
| 2931909000 |
|
|
|
| USP-1493000 |
Pamoic Acid (250 mg) |
130-85-8 |
|
| 2918290000 |
|
|
|
| USP-1494217 |
Pancuronium Bromide (500 mg) |
15500-66-0 |
UN2811 |
| USP-1494228 |
Pancuronium Bromide Related Compound A (15 mg) (1,1′-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) |
15500-65-9 |
UN2811 |
| USP-1494239 |
Pancuronium Bromide Related Compound B (15 mg) (1,1′-(17beta-Acetoxy-3alpha-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) |
41261-71-6 |
UN2811 |
| USP-1494240 |
Pancuronium Bromide Related Compound C (15 mg) (1,1′-(3alpha-acetoxy-17beta-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) |
27115-86-2 |
UN2811 |
| USP-1494501 |
Panthenol, Racemic (200 mg) |
16485-10-2 |
|
| 2936240100 |
|
|
|
